Article Sidebar
Article Details
Issue
Section
Articles
A. AFRICAN HEALTH SCIENCES OPEN ACCESS POLICY
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
In this issue
Abstract
I wish to welcome you to our second issue of Africa Health Sciences which is coming out just before Christmas, 2001.
While this is a festive season we in the Africa region have not got much to celebrate. It is the first anniversary of Dr. Mathew Lukwiya s tragic death at the hands of Ebola haemorrhagic fever. News from Gabon and the Democratic Republic of the Congo (DRC) is not good. They sighted some cases of haemorrhagic fever feared to be Ebola. The countries bordering the DRC are panicking because, as Ugandas commissioner for communicable diseases says, "; Ebola can travel across boundaries in a matter of hours. Even one thousand kilometers is not far enough. So be prepared!"; In light of this, African Health Sciences brings you an update on Ebola haemorrhagic fever in an article by some of the doctors who experienced the last Ebola outbreak in Gulu, northern Uganda last year, first hand1. They give us a glimpse of the epidemic as it affected children and adolescents, a sector of the population that is usually spared. Their take-home message is that we need to develop strategies to protect children and adolescents from exposure to Ebola patients. One such strategy is health education to children ad adolescents to avoid contact with Ebola patients.
In this issue of African Health Sciences we also bring you Dr. Nuru Nakintus results of a comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death2. Dr. Nakintu demonstrates that misporostol is cheaper and more effective than oxytocin in induction of labour in women with intrauterine fetal death. The study has very important implications for Obstetric practice in countries with limited resources such as Uganda.
We continue our series on the anti-microbial activities of extracts of several Ugandan medicinal plants with an article by Dr. Olila and colleagues3. In the current article they report results of their study of antibacterial and anti-fungal activities of two Ugandan medicinal plants.
One of the plants (W. ugandensis) had antibacterial activity against Escherichia coli and Staphylococcus aureus, as well as anti-fungal activity against Candiada albicans. However Z. cahlybeum had neither antifungal nor antibacterial activities. These are important findings since a large proportion of Africans still relies on the use of herbal remedies.
We welcome an article from the United Sates on contraceptive security, information flow and local adaptations to family planning practice in Morocco.4 Chandani and Breton use their Morocco experience tomake a few conclusions: both external and internal funding and technical expertise are critical components of a successful logistics system for supplying customers with the contraceptives they need, when, and where they need them.
In this era of escalating numbers of people with tuberculosis, it is essential to revisit methods of diagnosis. Erume and colleagues article5 on rapid detection of Mycobacterium avium subs. paratubeculosis using nested PCR, albeit in animals, demonstrates potential of this technology in the rapid diagnosis of paratuberculosis: a suspect causative agent of Crohns disease.
Dr Sydney Ogwals article on the bioavailability and stability of erythromycin delayed release tablets6 demonstrates how our own scientists, using relatively simple technology, can contribute to practical solution of common problems, and yet conform to international standards.
This issue of African Health Sciences concludes with two practical articles: one by Dr. Rosemary Byanyima on menstruation in an unusual place7, a manifestation of endometriosis in the thorax. The second one is an article by Dr. Mityuyasu, which we have reproduced with kind permission of Medscape. In this article Dr. Mitsuyasu explores the future of AIDS vaccines. He reminds us, if we need reminding, ";that over 58 million people worldwide have been infected with HIV since the beginning of the pandemic, and that almost 5.3 million were infected in 2000 alone. Historically vaccines have provided safe, cost effective, and efficient of preventing illness, disability, and death.";
The challenges of HIV vaccine development and implementation are enormous and extend beyond the scientific and medical communities into the realms of economics, politics, law and development. However there is some hope. Great hope. As one South African official said recently at the World AIDS Day Celebration in that country: the hope is that the majority of our people are not infected with HIV: and with appropriate interventions and change, we can contain the pandemic.
Editor.
Table of Contents
1. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intrauterine fetal death in Mulago Hospital, Kampala, Uganda. African Health Sciences 2001; 1(2): 55-59
2. Mupere E, Kaducu OF, Yoti Z. Ebola Haemorrhagic fever among hospitalised children and adolescents in Gulu, northern Uganda: epidemiologic and clinical observations. African Health Sciences 2001; 1(2): 60-65
3. Olila D, Olwa-Odyek, Opuda-Asibo. Antibacterial and antifungal activities of Zanthoxylum chalybeum and Warburgia ugandensis, Ugandan medicinal plants. African Health Sciences 2001; 1(2): 66-72
4. Chandani Y, Breton Y. Contraceptive security, information flow and local adaptations: family planning in Morocco. African Health Sciences 2001; 1(2): 73-81
5. Erume J, Spergser, Rosengarten R. Rapid detection of Mycobacterium avium subsp. paratuberculosis from cattle and zoo animals by nested PCR. African HealthSciences 2001; 1(2): 82-88
6. Ogwal S, Xide TU. Bioavailability and stability of erythromycin delayed release tablets. African Health Sciences 2001; 1(2): 89-95
7. Byanyima R K. Menstruation in an unusual place: a case of thoracic endometriosis, in Kampala, Uganda. African Health Sciences 2001; 1(2): 96-97
8. Mitsuyasu R. AIDS vaccine 2001: looking to the future.
Health Sciences 2001; 1(2): 51-52
While this is a festive season we in the Africa region have not got much to celebrate. It is the first anniversary of Dr. Mathew Lukwiya s tragic death at the hands of Ebola haemorrhagic fever. News from Gabon and the Democratic Republic of the Congo (DRC) is not good. They sighted some cases of haemorrhagic fever feared to be Ebola. The countries bordering the DRC are panicking because, as Ugandas commissioner for communicable diseases says, "; Ebola can travel across boundaries in a matter of hours. Even one thousand kilometers is not far enough. So be prepared!"; In light of this, African Health Sciences brings you an update on Ebola haemorrhagic fever in an article by some of the doctors who experienced the last Ebola outbreak in Gulu, northern Uganda last year, first hand1. They give us a glimpse of the epidemic as it affected children and adolescents, a sector of the population that is usually spared. Their take-home message is that we need to develop strategies to protect children and adolescents from exposure to Ebola patients. One such strategy is health education to children ad adolescents to avoid contact with Ebola patients.
In this issue of African Health Sciences we also bring you Dr. Nuru Nakintus results of a comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death2. Dr. Nakintu demonstrates that misporostol is cheaper and more effective than oxytocin in induction of labour in women with intrauterine fetal death. The study has very important implications for Obstetric practice in countries with limited resources such as Uganda.
We continue our series on the anti-microbial activities of extracts of several Ugandan medicinal plants with an article by Dr. Olila and colleagues3. In the current article they report results of their study of antibacterial and anti-fungal activities of two Ugandan medicinal plants.
One of the plants (W. ugandensis) had antibacterial activity against Escherichia coli and Staphylococcus aureus, as well as anti-fungal activity against Candiada albicans. However Z. cahlybeum had neither antifungal nor antibacterial activities. These are important findings since a large proportion of Africans still relies on the use of herbal remedies.
We welcome an article from the United Sates on contraceptive security, information flow and local adaptations to family planning practice in Morocco.4 Chandani and Breton use their Morocco experience tomake a few conclusions: both external and internal funding and technical expertise are critical components of a successful logistics system for supplying customers with the contraceptives they need, when, and where they need them.
In this era of escalating numbers of people with tuberculosis, it is essential to revisit methods of diagnosis. Erume and colleagues article5 on rapid detection of Mycobacterium avium subs. paratubeculosis using nested PCR, albeit in animals, demonstrates potential of this technology in the rapid diagnosis of paratuberculosis: a suspect causative agent of Crohns disease.
Dr Sydney Ogwals article on the bioavailability and stability of erythromycin delayed release tablets6 demonstrates how our own scientists, using relatively simple technology, can contribute to practical solution of common problems, and yet conform to international standards.
This issue of African Health Sciences concludes with two practical articles: one by Dr. Rosemary Byanyima on menstruation in an unusual place7, a manifestation of endometriosis in the thorax. The second one is an article by Dr. Mityuyasu, which we have reproduced with kind permission of Medscape. In this article Dr. Mitsuyasu explores the future of AIDS vaccines. He reminds us, if we need reminding, ";that over 58 million people worldwide have been infected with HIV since the beginning of the pandemic, and that almost 5.3 million were infected in 2000 alone. Historically vaccines have provided safe, cost effective, and efficient of preventing illness, disability, and death.";
The challenges of HIV vaccine development and implementation are enormous and extend beyond the scientific and medical communities into the realms of economics, politics, law and development. However there is some hope. Great hope. As one South African official said recently at the World AIDS Day Celebration in that country: the hope is that the majority of our people are not infected with HIV: and with appropriate interventions and change, we can contain the pandemic.
Editor.
Table of Contents
1. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intrauterine fetal death in Mulago Hospital, Kampala, Uganda. African Health Sciences 2001; 1(2): 55-59
2. Mupere E, Kaducu OF, Yoti Z. Ebola Haemorrhagic fever among hospitalised children and adolescents in Gulu, northern Uganda: epidemiologic and clinical observations. African Health Sciences 2001; 1(2): 60-65
3. Olila D, Olwa-Odyek, Opuda-Asibo. Antibacterial and antifungal activities of Zanthoxylum chalybeum and Warburgia ugandensis, Ugandan medicinal plants. African Health Sciences 2001; 1(2): 66-72
4. Chandani Y, Breton Y. Contraceptive security, information flow and local adaptations: family planning in Morocco. African Health Sciences 2001; 1(2): 73-81
5. Erume J, Spergser, Rosengarten R. Rapid detection of Mycobacterium avium subsp. paratuberculosis from cattle and zoo animals by nested PCR. African HealthSciences 2001; 1(2): 82-88
6. Ogwal S, Xide TU. Bioavailability and stability of erythromycin delayed release tablets. African Health Sciences 2001; 1(2): 89-95
7. Byanyima R K. Menstruation in an unusual place: a case of thoracic endometriosis, in Kampala, Uganda. African Health Sciences 2001; 1(2): 96-97
8. Mitsuyasu R. AIDS vaccine 2001: looking to the future.
Health Sciences 2001; 1(2): 51-52
